RxDoctor Payments Data
★ My doctorsLook up a doctor →

Mohammad Ahmad

Psychiatry · Alpharetta, GANPI 1831273036

Payments from drug & device makers

$3,133in general payments, 2019–2025

Across 147 payments — averaging $21.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$626
  • Johnson & Johnson$565
  • Otsuka America Pharmaceutical, Inc.$290
  • Lundbeck LLC$265
  • Sunovion Pharmaceuticals Inc.$237
  • Neos Therapeutics, LP$182
  • plus $969 from 16 others

What the payments were for

  • Food & beverage$2,98795%
  • Education$1465%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)34$626
Johnson & Johnson18$565
Otsuka America Pharmaceutical, Inc.15$290
Lundbeck LLC14$265
Sunovion Pharmaceuticals Inc.13$237
Neos Therapeutics, LP10$182
Abbott1$144
Takeda Pharmaceuticals U.S.A., Inc.10$142
Teva Pharmaceuticals USA, Inc.2$112
Alkermes, Inc.5$110
Shire North American Group Inc5$77
Ironshore Pharmaceuticals Inc.4$75
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$63
Corium, LLC3$51
Supernus Pharmaceuticals, Inc.2$47
Tris Pharma Inc2$33
Adlon Therapeutics L.p.2$31
Aytu Biopharma, Inc.1$22
Noven Therapeutics, LLC1$20
Jazz Pharmaceuticals Inc.1$17
Neurocrine Biosciences, Inc.1$13
Vertical Pharmaceuticals, LLC1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,133 in reported general payments places this provider in the 80th percentile of 900 psychiatry providers in Georgia.

See all psychiatry providers in Georgia →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate11$37,642
Aripiprazole75$3,586
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine92$2,470
Lurasidone Hcl14$1,407
Quetiapine Fumarate130$969
Dextroamphetamine Sulfate13$865
Oxcarbazepine15$825
Bupropion XlBupropion Hcl87$755
Olanzapine34$670
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine17$656
Duloxetine Hcl70$565
Hydroxyzine Hcl23$509
Fluoxetine Hcl33$471
Citalopram HbrCitalopram Hydrobromide16$433
Carbamazepine26$430

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$565$37,64211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 900 psychiatry providers in Georgia.

Other psychiatry in Alpharetta

See the full list for Georgia →

Where these figures come from

Is this you, or does something look wrong? →